Top Markets
Coin of the day
Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA
Rangering i aksjer #35931
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Aksjekurs
$0.016
Sist synkronisert: 2024-03-11
Markedsverdi
$3.27M
Endring (1 dag)
-5.33%
Endring (1 år)
0.00%
Land
US
Handel Invitae Corporation (NVTA)

Kategori

P/B-forhold for Invitae Corporation (NVTA)
P/B-forhold per 2026 TTM: 0
Ifølge Invitae Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Invitae Corporation fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US